Kovitz Investment Group Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$766K Buy
2,350
+1
+0% +$326 ﹤0.01% 855
2025
Q1
$634K Sell
2,349
-292
-11% -$78.8K ﹤0.01% 851
2024
Q4
$622K Buy
2,641
+210
+9% +$49.4K ﹤0.01% 838
2024
Q3
$579K Buy
+2,431
New +$579K ﹤0.01% 730